 |
Previous Article | Next Article 
The Journal of Neuroscience, April 1, 2000, 20(7):2589-2601
Phenotypic Knockout of Nerve Growth Factor in Adult Transgenic
Mice Reveals Severe Deficits in Basal Forebrain Cholinergic Neurons,
Cell Death in the Spleen, and Skeletal Muscle Dystrophy
Francesca
Ruberti1,
Simona
Capsoni1,
Alessandro
Comparini2,
Elena
Di
Daniel1,
Jessica
Franzot1,
Stefania
Gonfloni1,
Gabriella
Rossi1,
Nicoletta
Berardi2, and
Antonino
Cattaneo1
1 Neuroscience Program, International School for
Advanced Studies (SISSA), 34014 Trieste (Italy), and
2 Consiglio Nazionale delle Ricerche, Institute of
Neurophysiology, 56100 Pisa, Italy
The disruption of the nerve growth factor (NGF) gene in transgenic
mice leads to a lethal phenotype (Crowley et al., 1994) and hinders the
study of NGF functions in the adult. In this study the phenotypic
knockout of NGF in adult mice was achieved by expressing transgenic
anti-NGF antibodies, under the control of the human cytomegalovirus
promoter. In adult mice, antibody levels are 2000-fold higher than in
newborns. Classical NGF targets, including sympathetic and sensory
neurons, are severely affected. In the CNS, basal forebrain and
hippocampal cholinergic neurons are not affected in the early postnatal
period, whereas they are greatly reduced in the adult (55 and 62%
reduction, respectively). Adult mice show a reduced ability in spatial
learning behavioral tasks. Adult, but not neonatal, transgenic mice
further show a new phenotype at the level of peripheral tissues, such
as apoptosis in the spleen and dystrophy of skeletal muscles. The
analysis of this novel comprehensive transgenic model settles the
controversial issue regarding the NGF dependence of cholinergic neurons
in adult animals and reveals new NGF functions in adult non-neuronal
tissues. The results demonstrate that the decreased availability of NGF
in the adult causes phenotypic effects via processes that are at least
partially distinct from early developmental effects of NGF deprivation.
Key words:
adult transgenic mice; neurotrophins; cholinergic
deficits; behavioral impairment; muscular dystrophy; apoptosis; spleen
Copyright © 2000 Society for Neuroscience 0270-6474/00/2072589-13$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
D. Deponti, R. Buono, G. Catanzaro, C. De Palma, R. Longhi, R. Meneveri, N. Bresolin, M. T. Bassi, G. Cossu, E. Clementi, et al.
The Low-Affinity Receptor for Neurotrophins p75NTR Plays a Key Role for Satellite Cell Function in Muscle Repair Acting via RhoA
Mol. Biol. Cell,
August 15, 2009;
20(16):
3620 - 3627.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Caporali and C. Emanueli
Cardiovascular Actions of Neurotrophins
Physiol Rev,
January 1, 2009;
89(1):
279 - 308.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Rosato-Siri, A. Cattaneo, and E. Cherubini
Nicotine-induced enhancement of synaptic plasticity at CA3-CA1 synapses requires GABAergic interneurons in adult anti-NGF mice
J. Physiol.,
October 15, 2006;
576(2):
361 - 377.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. N. Pearse, S. L. Swendeman, Y. Li, D. Rafii, and B. L. Hempstead
A neurotrophin axis in myeloma: TrkB and BDNF promote tumor-cell survival
Blood,
June 1, 2005;
105(11):
4429 - 4436.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. De Rosa, A. A. Garcia, C. Braschi, S. Capsoni, L. Maffei, N. Berardi, and A. Cattaneo
Intranasal administration of nerve growth factor (NGF) rescues recognition memory deficits in AD11 anti-NGF transgenic mice
PNAS,
March 8, 2005;
102(10):
3811 - 3816.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Coppola, C. A. Barrick, E. A. Southon, A. Celeste, K. Wang, B. Chen, E.-B. Haddad, J. Yin, A. Nussenzweig, A. Subramaniam, et al.
Ablation of TrkA function in the immune system causes B cell abnormalities
Development,
October 15, 2004;
131(20):
5185 - 5195.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Capsoni, S. Giannotta, M. Stebel, A. A. Garcia, R. de Rosa, G. Villetti, B. P. Imbimbo, C. Pietra, and A. Cattaneo
Ganstigmine and donepezil improve neurodegeneration in AD11 antinerve growth factor transgenic mice
American Journal of Alzheimer's Disease and Other Dementias,
May 1, 2004;
19(3):
153 - 160.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. Jockers-ScheruBl, U. Matthies, H. Danker-Hopfe, U. E. Lang, R. Mahlberg, and R. Hellweg
Chronic Cannabis Abuse Raises Nerve Growth Factor Serum Concentrations in Drug-Naive Schizophrenic Patients
J Psychopharmacol,
December 1, 2003;
17(4):
439 - 445.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Jendreyko, M. Popkov, R. R. Beerli, J. Chung, D. B. McGavern, C. Rader, and C. F. Barbas III
Intradiabodies, Bispecific, Tetravalent Antibodies for the Simultaneous Functional Knockout of Two Cell Surface Receptors
J. Biol. Chem.,
November 28, 2003;
278(48):
47812 - 47819.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Garaci, S. Aquaro, C. Lapenta, A. Amendola, M. Spada, S. Covaceuszach, C.-F. Perno, and F. Belardelli
Anti-nerve growth factor Ab abrogates macrophage-mediated HIV-1 infection and depletion of CD4+ T lymphocytes in hu-SCID mice
PNAS,
July 22, 2003;
100(15):
8927 - 8932.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Capsoni, S. Giannotta, and A. Cattaneo
Nerve growth factor and galantamine ameliorate early signs of neurodegeneration in anti-nerve growth factor mice
PNAS,
September 17, 2002;
99(19):
12432 - 12437.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. S. Auld, F. Mennicken, and R. Quirion
Nerve Growth Factor Rapidly Induces Prolonged Acetylcholine Release from Cultured Basal Forebrain Neurons: Differentiation between Neuromodulatory and Neurotrophic Influences
J. Neurosci.,
May 15, 2001;
21(10):
3375 - 3382.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. A. Dissen, C. Romero, A. N. Hirshfield, and S. R. Ojeda
Nerve Growth Factor Is Required for Early Follicular Development in the Mammalian Ovary
Endocrinology,
May 1, 2001;
142(5):
2078 - 2086.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. Capsoni, G. Ugolini, A. Comparini, F. Ruberti, N. Berardi, and A. Cattaneo
Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice
PNAS,
June 6, 2000;
97(12):
6826 - 6831.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. N. Melnikova and P. D. Gardner
The Signal Transduction Pathway Underlying Ion Channel Gene Regulation by Sp1-c-Jun Interactions
J. Biol. Chem.,
May 25, 2001;
276(22):
19040 - 19045.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Rajpal and T. G. Turi
Intracellular Stability of Anti-caspase-3 Intrabodies Determines Efficacy in Retargeting the Antigen
J. Biol. Chem.,
August 24, 2001;
276(35):
33139 - 33146.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|